Cartesian Therapeutics, Inc. (NASDAQ:RNAC) insiders have significant skin in the game with 58% ownership

To get a sense of who is truly in control of Cartesian Therapeutics, Inc. (NASDAQ:RNAC), it is important to understand the ownership structure of the business. We can see that individual insiders own ...

Cartesian Therapeutics Announces Strong Efficacy Signal in Phase 2 Trial of Descartes-08 in Patients with SLE and Expansion of Clinical Development into Myositis

LLDAS response rate observed in patients with SLE who received Descartes-08 in Phase 2 open-label trial reaching Month 3 follow-up (n=3) Disease remission reported as DORIS response seen in 2 out of 3 ...
Billboard

Gospel Digital Song Sales

THE WEEK'S TOP-DOWNLOADED GOSPEL SONGS, AS COMPILED BY LUMINATE. click to see more PureSprings Gospel/Fair Trade PureSprings Gospel/Fair Trade Gains In Performance DSMG/Hallwood Gains In Performance ...